Capstan Medical
Santa Cruz, California heart-robotics company founded 2020; develops a catheter-based robotic platform for mitral valve replacement, $141 million raised.
Capstan Medical is a medical robotics company founded in 2020 out of the Santa Cruz, California incubator Occam Labs by Dan Wallace, with teams based in Santa Cruz and Portola Valley, California. Maggie Nixon, a former senior engineer and executive at Intuitive Surgical, joined as chief executive in 2022.
The company is developing a robotic delivery platform paired with catheter-based technology and implants to treat structural heart disease, with an initial focus on mitral valve regurgitation as a less invasive, catheter-based alternative to open-heart valve replacement and repair surgery. In early 2025, Capstan completed the first-in-human robotic-assisted transcatheter mitral valve replacement procedures, described as the first clinical use of a minimally invasive robotic structural heart platform. The system remains in clinical investigation and is not yet commercially available.
Capstan Medical raised a $110 million Series C round in December 2024, bringing total funding to $141 million.
Primary type & automation activities this supplier delivers:
Robotic Structural Heart Platform
Catheter-based robotic delivery system for transcatheter mitral valve replacement targeting structural heart disease.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
-
9
How Yuanhua Robotics’ 5,000 Surgeries Are Redefining Trust in China’s AI Surgical Robots RobotToday · Oct 16, 2025
- 10
- 11
- 12
- 13
- 14
- 15
-
16
RobotToday Weekly October 12 – 16, 2026 RobotToday · Oct 17, 2026
- 17
- 18
-
19
Suzy Teele’s Mission at ARM Institute RobotToday · Oct 13, 2026
- 20
Contact Capstan Medical
WEBSITE
https://capstanmedical.comHEADQUARTERS
United States
Company Facts
Founded
2020
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
